Cairo – Mubasher: Memphis Pharmaceutical said its pretax profits declined 71.4% in the first half of the fiscal year 2016 – 2017.
The drug producer reported profits before tax of EGP 152,000 in the first half of 2016 – 2017 down from EGP 532,000 for the similar period a year earlier.
Earlier, the company reported its net profits for the first four months of FY16 – 17 that slipped by 89.9% to EGP 42,000.
